132 related articles for article (PubMed ID: 37824802)
21. Human papillomavirus testing using existing nucleic acid testing platforms to screen women for cervical cancer: implementation studies from five sub-Saharan African countries.
Joseph J; Demke O; Ameyan L; Bitilinyu-Bango J; Bourgoin B; Diop M; Guèye B; Kama J; Lubega M; Madzima B; Maparo T; Mhizha T; Musoke A; Nabadda S; Phiri T; Tchereni T; Wiwa O; Hariharan K; Peter T; Khan S
BMJ Open; 2023 Jan; 13(1):e065074. PubMed ID: 36609331
[TBL] [Abstract][Full Text] [Related]
22. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.
Flores Y; Shah K; Lazcano E; Hernández M; Bishai D; Ferris DG; Lörincz A; Hernández P; Salmerón J;
Salud Publica Mex; 2002; 44(4):335-44. PubMed ID: 12216521
[TBL] [Abstract][Full Text] [Related]
23. Upscaling cervical cancer screening and treatment for women living with HIV at a rural referral hospital in Tanzania: protocol of a before-and-after study exploring HPV testing and novel diagnostics.
Di Salvo I; Mnzava D; Nicoletti GJ; Senkoro E; Ndege RC; Huang DJ; Makunja NT; Kassiga GI; Kaufmann AM; Weisser M; Kind AB
BMC Health Serv Res; 2023 Mar; 23(1):234. PubMed ID: 36894985
[TBL] [Abstract][Full Text] [Related]
24. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
[No Abstract] [Full Text] [Related]
25. Acting on the call for cervical cancer elimination: Planning tools for low- and middle- income countries to increase the coverage and effectiveness of screening and treatment.
Herrick T; Thomson KA; Shin M; Gannon S; Tsu V; de Sanjosé S
BMC Health Serv Res; 2022 Oct; 22(1):1246. PubMed ID: 36241993
[TBL] [Abstract][Full Text] [Related]
26. Barriers and Facilitators to Cervical Cancer Screening Among Women in Rural Ontario, Canada: The Role of Self-Collected HPV Testing.
Racey CS; Gesink DC
J Rural Health; 2016; 32(2):136-45. PubMed ID: 26265118
[TBL] [Abstract][Full Text] [Related]
27. Self-collection based HPV testing for cervical cancer screening among women living with HIV in Uganda: a descriptive analysis of knowledge, intentions to screen and factors associated with HPV positivity.
Mitchell SM; Pedersen HN; Eng Stime E; Sekikubo M; Moses E; Mwesigwa D; Biryabarema C; Christilaw J; Byamugisha JK; Money DM; Ogilvie GS
BMC Womens Health; 2017 Jan; 17(1):4. PubMed ID: 28086933
[TBL] [Abstract][Full Text] [Related]
28. Health impact of delayed implementation of cervical cancer screening programs in India: A modeling analysis.
Campos NG; Tsu V; Jeronimo J; Regan C; Resch S; Clark A; Sy S; Kim JJ
Int J Cancer; 2019 Feb; 144(4):687-696. PubMed ID: 30132850
[TBL] [Abstract][Full Text] [Related]
29. A Randomized Clinical Trial of Human Papillomavirus Test-and-Treat as Compared to Cytology-Based Screening for Prevention of Cervical Cancer Among Women With Human Immunodeficiency Virus: AIDS Clinical Trials Group Protocol A5282.
Wilkin T; Chen H; Sahasrabuddhe V; Matining R; Mngqibisa R; Chinula L; Mbilizi Y; Magure T; Omoz-Oarhe AE; Rassool M; Riviere C; Bhosale R; Godbole S; Naranjo R; Coombs R; Michelow P; Godfrey C; Firnhaber C
Clin Infect Dis; 2022 Oct; 75(8):1280-1288. PubMed ID: 35294524
[TBL] [Abstract][Full Text] [Related]
30. Prospective cohort study examining cervical cancer screening methods in HIV-positive and HIV-negative Cambodian Women: a comparison of human papilloma virus testing, visualization with acetic acid and digital colposcopy.
Thay S; Goldstein A; Goldstein LS; Govind V; Lim K; Seang C
BMJ Open; 2019 Feb; 9(2):e026887. PubMed ID: 30804036
[TBL] [Abstract][Full Text] [Related]
31. The Clinical and Economic Benefits of Co-Testing Versus Primary HPV Testing for Cervical Cancer Screening: A Modeling Analysis.
Felix JC; Lacey MJ; Miller JD; Lenhart GM; Spitzer M; Kulkarni R
J Womens Health (Larchmt); 2016 Jun; 25(6):606-16. PubMed ID: 27023044
[TBL] [Abstract][Full Text] [Related]
32. Screening for cancer in low- and middle-income countries.
Sankaranarayanan R
Ann Glob Health; 2014; 80(5):412-7. PubMed ID: 25512156
[TBL] [Abstract][Full Text] [Related]
33. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
Wright TC; Denny L; Kuhn L; Pollack A; Lorincz A
JAMA; 2000 Jan; 283(1):81-6. PubMed ID: 10632284
[TBL] [Abstract][Full Text] [Related]
34. Genital Cancers in Women: Cervical Cancer.
Morris E; Roett MA
FP Essent; 2015 Nov; 438():18-23. PubMed ID: 26569047
[TBL] [Abstract][Full Text] [Related]
35. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
Zhao D; Zhang L; Xie F; Peng D; Wei J; Jiang L; Zhang S; Qi D
BMC Cancer; 2020 Aug; 20(1):810. PubMed ID: 32847541
[TBL] [Abstract][Full Text] [Related]
36. Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
Moscicki AB; Flowers L; Huchko MJ; Long ME; MacLaughlin KL; Murphy J; Spiryda LB; Gold MA
J Low Genit Tract Dis; 2019 Apr; 23(2):87-101. PubMed ID: 30907775
[TBL] [Abstract][Full Text] [Related]
37. Effect of vaginal self-sampling on cervical cancer screening rates: a community-based study in Newfoundland.
Duke P; Godwin M; Ratnam S; Dawson L; Fontaine D; Lear A; Traverso-Yepez M; Graham W; Ravalia M; Mugford G; Pike A; Fortier J; Peach M
BMC Womens Health; 2015 Jun; 15():47. PubMed ID: 26060041
[TBL] [Abstract][Full Text] [Related]
38. Benefits and potential harms of human papillomavirus (HPV)-based cervical cancer screening: A real-world comparison of HPV testing versus cytology.
Thomsen LT; Kjaer SK; Munk C; Ørnskov D; Waldstrøm M
Acta Obstet Gynecol Scand; 2021 Mar; 100(3):394-402. PubMed ID: 33566361
[TBL] [Abstract][Full Text] [Related]
39. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
40. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]